Soc. Generale Call 106 ABT 21.06..../ DE000SQ3TJJ5 /
10/06/2024 10:57:00 | Var.-0.030 | Denaro11:30:45 | Lettera11:30:45 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.260EUR | -10.34% | 0.250 Quantità in denaro: 10,000 |
0.310 Quantità in lettera: 10,000 |
Abbott Laboratories | 106.00 USD | 21/06/2024 | Call |
GlobeNewswire
11:00
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire
11:00
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire
11:00
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
10:00
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
GlobeNewswire
10:00
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moder...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...